Medicinal – Page 162

Identification of an antifungal lipopeptide from Bacillus amyloliquefaciens HAU3 inhibiting the growth of Fusarium graminearum using preparative chromatography and 2D-NMR

mycolabadmin

Scientists discovered a beneficial soil bacterium called Bacillus amyloliquefaciens that produces a natural antifungal compound called fengycin, which effectively kills dangerous mold (Fusarium graminearum) that contaminates animal feed. This bacterium can be used as a biological control agent to prevent fungal growth and reduce harmful mycotoxins in livestock feed, offering a safer and more environmentally friendly alternative to chemical fungicides. The study shows the bacterium’s compounds damage fungal cell membranes and generate harmful stress molecules that kill the fungus.

Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability

mycolabadmin

Researchers tested a new antifungal drug called olorofim against 253 different Fusarium fungi that infect humans. Fusarium is particularly dangerous for people with weakened immune systems and resists most common antifungals. The study found that olorofim works, but its effectiveness varies significantly depending on which type of Fusarium is present. While these lab results are promising, additional testing in animal models is needed before it can be used clinically.

A broad-spectrum anti-fungal effector dictates bacterial-fungal interkingdom interactions

mycolabadmin

Scientists discovered that a common soil bacterium called Acidovorax citrulli has a sophisticated weapon to fight dangerous fungi. This bacterium uses a needle-like structure to inject a toxic protein called TseN directly into fungal cells, where it damages the fungal DNA and causes death. This new discovery is particularly exciting because it works against drug-resistant fungi like Candida auris that are increasingly hard to treat. Tests in mice confirmed that this bacterial attack significantly reduces fungal infections on skin.

Extensive erythematous plaques of fungal origin in an overseas student: Cutaneous manifestation of coccidioidomycosis

mycolabadmin

A 21-year-old student studying in Arizona developed unusual skin rashes months after returning to China. Doctors had difficulty diagnosing the condition because it lacked typical symptoms of the fungal infection coccidioidomycosis. By using multiple diagnostic methods including DNA sequencing and fungal culture, they identified the infection as caused by Coccidioides posadasii. When the initial antifungal drug didn’t work, testing showed the fungus was resistant, so they switched to a different antifungal called voriconazole, which successfully cured the infection after 12 months.

Influences of substrate and tissue type on erinacine production and biosynthetic gene expression in Hericium erinaceus

mycolabadmin

Researchers studied how different growing conditions affect erinacine production in lion’s mane mushroom mycelium. They found that the type of nutrients provided (substrate) significantly influences which erinacines are produced, even when the genes responsible for making these compounds show similar activity levels. Mycelium produced much more erinacines than fruit bodies, and specific nutrients could be used to encourage production of specific beneficial compounds.

Renaming Candida glabrata—A case of taxonomic purity over clinical and public health pragmatism

mycolabadmin

Candida glabrata is a common yeast infection that causes serious illnesses in humans, affecting millions of people worldwide. Scientists have recently proposed renaming it to Nakaseomyces glabrata for technical taxonomic reasons. However, this article argues against the change because it would create confusion for doctors, complicate treatment instructions on medications, disrupt disease tracking systems, and make it harder for patients to understand their conditions. Keeping the familiar name Candida glabrata is more practical and helpful for patient care and public health than strict adherence to taxonomic classification rules.

Chronic Urticaria Suspected to be Caused by a 13.5 mg Levonorgestrel Intrauterine Device (Skyla®)

mycolabadmin

A woman developed a chronic hive-like rash that lasted for two years after having a hormone-releasing intrauterine device (Skyla®) implanted. Extensive medical testing ruled out common causes like vitamin D deficiency and allergies. When the device was removed, the rash gradually disappeared completely over two years. This case suggests that the progesterone released from the device may have triggered an allergic reaction in this particular patient.

Identification of Non-fumigatus Aspergillus Species in Clinical Samples from Southern California

mycolabadmin

Researchers in Southern California studied fungal infections caused by Aspergillus, a common mold that can infect humans. They found that species other than the traditionally dangerous A. fumigatus are now being detected more frequently in patient samples, particularly from skin and respiratory infections. These non-fumigatus species showed interesting seasonal patterns and some may be resistant to standard antifungal treatments, suggesting doctors may need to adjust their treatment strategies.

Superhydrophobic Fatty Acid-Based Spray Coatings with Dual-Mode Antifungal Activity

mycolabadmin

Researchers developed special water-repellent coatings made from natural fatty acids that can prevent fungal infections. These coatings work in two ways: they physically prevent fungi from sticking to surfaces through their bumpy structure, and they chemically kill fungi that do land on them. The coatings can be easily sprayed on like paint and offer an environmentally friendly alternative to traditional antifungal treatments that are becoming less effective.

Epidemiology and outcomes of Candida-associated osteoarticular infections: A multicentre retrospective study from Turkey

mycolabadmin

Researchers in Turkey studied 73 patients with rare bone and joint infections caused by Candida fungi over 10 years. They found that about half of the infections were caused by species other than the common C. albicans, with some showing resistance to fluconazole antibiotics. Surgical procedures to clean out infected tissue significantly improved patient recovery, while patients with diabetes had worse outcomes and recovered less completely.

Research Topic: Medicinal